Eli Lilly

Senior Director, Market Access - Lilly Regenerative Medicine (LRM)

Eli Lilly • $181K — $266K *
Boston, MA 02115In-Person
Pharmaceuticals & Biotech
8 - 10 years of experience
Today
Be an Early Applicant
Job Overview by Ladders

Qualifications

  • Bachelor's degree.
  • 10+ years of experience in market access, pricing, or payer strategy within biopharma.
  • Hands-on ownership of global or multi-country pricing and access strategy.
  • Familiarity with payer, HTA, and reimbursement systems in major markets (US, China, EU, Japan).
  • Proven track record of creating a pricing or access framework from ground up.

Responsibilities

  • Develop a unified global pricing and access strategy for LRM assets.
  • Establish personalized access strategies for each asset at critical milestones.
  • Determine global versus local pricing strategies per asset's specific needs.
  • Initiate pilots to enhance Lilly's overall market access capacity.
  • Create standard playbook for innovative contract structures for gene therapies.
  • Lead the value narrative for global dossier submissions.
  • Guide Lilly's governance on pricing at major project milestones.

Benefits

  • Eligibility to participate in a company-sponsored 401(k) and pension plan.
  • Comprehensive medical, dental, vision, and prescription drug benefits.
  • Flexible spending accounts for healthcare and dependent care.
  • Generous vacation and leave of absence policies.
  • Access to well-being programs including fitness benefits and employee clubs.
Full Job Description
About the Role

The Senior Director, Market Access is LRM's senior strategic owner of global market access strategy across the gene therapy portfolio - including ultra-rare disease assets and common-disease assets such as wet AMD. LRM has no market access staff of its own in-market; that work sits within Lilly Value & Access (LV&A, US) and International Value & Access (IVA, OUS/IBU). This role owns the strategy layer neither function is built to solve alone: one cross-asset pricing and contracting logic, and new payment mechanics for one-time curative therapies. It sets the frame that LV&A and IVA then apply and negotiate market by market - without duplicating the in-market negotiation, payer relationship management, or country-level execution those teams already own.

Core Competencies

  • Own the Strategy Layer - Set one global pricing, access, and contracting frame for LRM assets and work closely with LV&A and IVA to customize, where needed, by market.
  • Pioneer Payment Models - Build Lilly's first playbook for durability-linked and outcomes-based contracts for one-time gene therapies.
  • Translate Evidence to Value - Own the strategic value proposition narrative that supports global value dossiers, ultimately localized by LV&A and IVA for payers and HTA bodies.
  • Represent LRM Externally - Shape policy and payer precedent for cell and gene therapies, in coordination with Lilly government affairs.
  • Safeguard Portfolio Coherence - Ensure cross-asset pricing/contracting consistency and a clear, efficiency ways of working with core partners within LRM and across Lilly.


Responsibilities

Access & Pricing Strategy
  • Build one global pricing and access framework - value-driver logic, utility and frame for novel contracting approaches, assumptions driving durability arguments - used across every LRM asset from Phase 2 forward.
  • Establish access positioning for each asset ahead of key inflection points (pivotal readout, filing, launch), and align with LV&A and IVA early to ensure positioning is relevant and can be customized locally by market.
  • Decide, asset by asset, what elements of a single global position should be maintained (e.g., ultra-rare, single-payer-per-country markets) versus where affiliates need latitude to flex terms locally.
  • Determine and partner internally to execute pilots that advance Lilly's market access capabilities that are applicable across Lilly (including but not limited to LRM).

Novel Payment & Contracting Models (~30%)
  • Build Lilly's first standardized playbook for durability-linked and outcomes-based contracts for one-time gene therapies (e.g., contract archetypes, the registry/claims data needed to track re-treatment or loss of effect, and the financial modeling assumptions behind each structure), taking into account and building from existing Lilly and other industry experience.

Payer, HTA, and Health System Engagement
  • Own the strategic narrative and evidence prioritization behind each LRM asset's global value dossier (the core value story and HTA submission strategy).
  • Represent LRM specifically in external forums shaping how one-time curative therapies get evaluated and paid for (e.g., ICER methods work, Alliance for Regenerative Medicine policy committees), coordinating with central Lilly government affairs so LRM speaks with one position on gene-therapy-specific policy questions.

Organizational Interface
  • Serve as the strategic driver through Lilly governance processes on pricing and access at each major gate (e.g., pivotal readout, regulatory filing, launch readiness review).
  • Hold single-point accountability for cross-asset consistency - e.g., ensuring wet AMD and an ultra-rare gene therapy don't set pricing or contracting precedents in the same market that create policy risk for each other.


Basic Qualifications

  • Bachelor's degree.
  • 10+ years of progressive market access, pricing, or payer strategy experience in biopharma, including direct ownership (not just contribution to) a global or multi-country pricing and access strategy.
  • Working knowledge of payer, HTA, and reimbursement systems in major international markets (e.g., US, China, France, Germany, Japan, and UK).
  • Demonstrated experience building a pricing, access, or contracting framework from scratch, without an established internal precedent or template to adapt.


Preferred Qualifications

  • Direct experience negotiating or structuring cell or gene therapy access, pricing, or contracting deals.
  • Experience partnering with limited-distribution networks or Centers of Excellence in a prior cell/gene therapy launch.
  • Experience building a net-new market access capability - i.e., establishing the first version of a process, not scaling an existing one.
  • Direct experience negotiating outcomes-based, value-based, or annuity/installment payment structures with a named payer or health system.


Additional Information

  • Travel: Est. 10-20%, domestic and international, for payer, HTA, and policy engagement.

Actual compensation will depend on a candidate's education, experience, skills, and geographic location. The anticipated wage for this position is
$181,500 - $266,200

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly's compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly

About Eli Lilly

ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in the commercialization of treatments for unmet medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. It is the developer of a treatment known as Cialis (tadalafil), a product for the treatment of erectile dysfunction through its joint venture with Eli Lilly and Company in North America and Europe. It is also engaged in contract manufacturing services for third parties. It is in a strategic alliance with Solvay Pharmaceuticals, Inc. ICOS Corporation was established in 1989, based in Bothell, Washington. It is currently operated by Eli Lilly and Company.

Eli Lilly Careers

Joining Eli Lilly offers an unparalleled opportunity to become part of a leading global team dedicated to creating a healthier future. As a company revered for its commitment to innovation and leadership in the pharmaceutical industry, Eli Lilly is where your professional journey can flourish. Work You’ll Do At Eli Lilly, we are passionate about transforming patient care and advancing medical innovation. Our team at Eli Lilly is at the forefront of developing groundbreaking solutions in healthcare. By joining us, you will collaborate with some of the brightest minds in the industry, using cutting-edge technology to make real-world impacts. Lead with Innovation and Leadership Eli Lilly stands out in the marketplace by integrating deep industry expertise with robust research and development efforts. We are looking for professionals who are eager to drive change and lead the way in developing therapeutic breakthroughs. Explore Job Opportunities and Growth Eli Lilly offers a variety of career paths, including full-time positions and internships, across multiple functions such as research, marketing, IT, and sales. Whether you are a seasoned professional or a recent graduate, Eli Lilly provides an environment that promotes career growth and learning opportunities. Our commitment to diversity and leadership training ensures that every employee can achieve their potential. Be Part of Our Team Our team at Eli Lilly is committed to excellence and driven by a mission to improve lives. Employees enjoy a supportive culture that values collaboration, creativity, and diversity. We believe that a diverse workforce fosters innovation and helps us better connect with the communities we serve. Benefits and Culture Eli Lilly is dedicated to supporting our employees, offering competitive benefits, wellness programs, and comprehensive health care. Our culture is built on a foundation of respect, integrity, and quality, making Eli Lilly not just a great place to work, but a community to grow with. Networking and Professional Development Eli Lilly encourages continuous professional development and networking. With access to various training programs and mentorship opportunities, employees can enhance their skills and advance their careers. Our leadership is committed to nurturing talent through effective training and development strategies. Join Our Team Discover the exciting job opportunities at Eli Lilly by exploring open positions that match your skills and interests. We are continuously hiring and looking for individuals who are passionate, innovative, and ready to contribute to our mission of making life better for people around the globe. Stay Connected Keep up to date with the latest at Eli Lilly by following our careers blog. Gain insights from industry leaders and get tips on everything from crafting the perfect resume to preparing for your interview. Eli Lilly is not just a company—it's a place where you can make a difference. Explore the positions available and find out how your talents can help change the world. SEARCH ELI LILLY JOBS Stay ahead in your career with Eli Lilly, where innovation, leadership, and a commitment to diversity and growth lead the way to future advancements.
Learn more about Eli Lilly
Size
35,000 employees
Market Cap
$344.2 billion
Industry
Pharmaceuticals & Biotech
Net Income
$6.1 billion
Founded
1876
5 Year Trend
+5.9%
Revenue
$24.5 billion
NASDAQ
LLY
* Ladders Estimates

Similar Jobs

Ad banner background

Get Ready For Your
Next Interview

More Jobs at Eli Lilly

More Pharmaceuticals & Biotech Jobs

Find similar Senior Director, Market Access - Lilly Regenerative Medicine (LRM) jobs:

NationwideBoston, MA